Can metacognitive therapy help depressed workers return to work?
NCT ID NCT07349550
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how thinking skills (like memory and focus) are linked to sick leave in people with depression or anxiety. Researchers will give metacognitive therapy with a work focus to 200 patients at risk of sick leave. They want to see if the therapy improves symptoms and helps people return to work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- metacognitive therapy
- What this could lead to
- If successful, this could point toward better ways to help people with depression or anxiety return to work by targeting cognitive difficulties.
- What could go wrong
- This is an observational study with only 200 participants, so results may not apply to everyone. It is not testing a new drug or cure, and the therapy may not work for all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diakonhjemmet hospital
RECRUITINGOslo, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Nature as therapy? a new trial tests outdoor outings for anxious kids